• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
N-Acetyl-S-(N′-phenylthiocarbamoyl)-L-cysteine

N-Acetyl-S-(N′-phenylthiocarbamoyl)-L-cysteine

Product ID A0910
Cas No.
Purity ≥98%
Product Unit SizeCostQuantityStock
10 mg $101.00 In stock
25 mg $201.00 In stock
100 mg $591.00 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

N-Acetyl-S-(N’-phenylthiocarbamoyl)-L-cysteine (PITC) is a cysteine conjugate of N-acetyl-phenylisothiocyanate. Isothiocyanates are typically found in plants of the Brassicaceae family, including broccoli, cabbage, and radish. Isothiocyanates are best known for their antioxidative, anticancer chemotherapeutic, chemopreventive, anti-angiogenic, and antibiotic properties. PITC also exhibits vasodilatory properties that are linked to its release of H2S, causing membrane depolarization of vascular smooth muscle cells. PITC inhibits lipid peroxidation, scavenges hydroxyl radicals, and decreases nitrite production in vivo, inhibiting tumor development and increasing life span in animal models of cancer. Additionally, PITC decreases expression of VEGF, IL-1β, IL-6, GM-CSF, and TNF-α and increases expression of IL-2 and tissue inhibitor of metalloproteinase 1 (TIMP1), inhibiting cell proliferation in vitro; these anti-angiogenic effects also occur in vivo, as PITC decreases capillary formation and vessel outgrowth in animal models. PITC exhibits antibacterial activity against species of Bacillus, Staphylococcus, Enterococcus, Salmonella, and Enterobacter, altering surface charge and hydrophilicity, resulting in membrane depolarization and cell death; it also displays anti-parasitic activity against nematodes of the genus Heterodera. This compound shows immunomodulatory activity as well, increasing total white blood cell count, antibody titer, and number of plaque-forming cells in animal models.

Product Info

Purity

≥98%

Formula

C12H14N2O3S2

Formula Wt.

298.38

Chemical Name

N-Acetyl-S-(N′-phenylthiocarbamoyl)-L-cysteine

Synonym

Phenylisothiocyanate N-acetyl-L-cysteine

Appearance

White to off white powder

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

A0910 MSDS PDF

Info Sheet

A0910 Info Sheet PDF

References

Martelli A, Testai L, Citi V, et al. Pharmacological characterization of the vascular effects of aryl isothiocyanates: Is hydrogen sulfide the real player? Vascul Pharmacol. 2013 Nov 25. pii: S1537-1891(13)00138-9. PMID: 24287004.

Abreu AC, Borges A, Simões LC, et al. Antibacterial activity of phenyl isothiocyanate on Escherichia coli and Staphylococcus aureus. Med Chem. 2013 Aug;9(5):756-61. PMID: 22974327.

Schroeder NE, Macguidwin AE. Mortality and behavior in Heterodera glycines juveniles following exposure to isothiocyanate compounds. J Nematol. 2010 Sep;42(3):194-200. PMID: 22736856.

Beevi SS, Mangamoori LN, Dhand V, et al. Isothiocyanate profile and selective antibacterial activity of root, stem, and leaf extracts derived from Raphanus sativus L. Foodborne Pathog Dis. 2009 Jan-Feb;6(1):129-36. PMID: 19182965.

Thejass P, Kuttan G. Inhibition of endothelial cell differentiation and proinflammatory cytokine production during angiogenesis by allyl isothiocyanate and phenyl isothiocyanate. Integr Cancer Ther. 2007 Dec;6(4):389-99. PMID: 18048887.

Thejass P, Kuttan G. Allyl isothiocyanate (AITC) and phenyl isothiocyanate (PITC) inhibit tumour-specific angiogenesis by downregulating nitric oxide (NO) and tumour necrosis factor-alpha (TNF-alpha) production. Nitric Oxide. 2007 Mar;16(2):247-57. PMID: 17097904.

Manesh C, Kuttan G. Effect of naturally occurring isothiocyanates on the immune system. Immunopharmacol Immunotoxicol. 2003 Aug;25(3):451-9. PMID: 19180807.

Manesh C, Kuttan G. Anti-tumour and anti-oxidant activity of naturally occurring isothiocyanates. J Exp Clin Cancer Res. 2003 Jun;22(2):193-9. PMID: 12866569.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • T9968

    Tyrphostin A25

    SK K+ channel blocker, EGFR inhibitor.

    ≥98%
  • Z160021

    Zearalanone

    Mycotoxin.

    ≥97%
  • M2077

    1-Methoxy-5-methylphenazinium Methyl Sulfate

    Electron carrier used to study dehydrogenase el...

    ≥98%
  • P200099

    PF-06939999

    PRMT5 inhibitor

    ≥98%
  • D0005

    Dabrafenib Mesylate

    B-Raf and c-Raf inhibitor.

    ≥98%
  • P3469

    Pirfenidone

    Collagen synthesis inhibitor.

    ≥98%
  • A0916

    Acepromazine Maleate

    Phenothiazine derivative; D1/2 and 5-HT1A/2A an...

    ≥99%
  • C4658

    Clopidogrel Sulfate

    Thienopyridine; P2Y12 antagonist.

    ≥98%
  • P1917

    Phenylethyl 3-methylcaffeate

    Derivative of methyl caffeate, hydroxycinnamic ...

    ≥97%
  • N1744

    Nelarabine

    Nucleoside (guanosine) analog; DNA chain termin...

    ≥98%
  • L9602

    LY-2874455

    FGFR inhibitor.

    ≥98%
  • P3540

    PIK-75 Hydrochloride

    p110α PI3K inhibitor.

    ≥98%
  • B0150

    Bambuterol Hydrochloride

    β2-adrenergic agonist, BChE inhibitor.

    ≥98%
  • K6276

    (E)-KPT-330

    CRM1-selective inhibitor of nuclear export.

    ≥99%
  • E9317

    Exemestane

    Aromatase inhibitor.

    ≥97%
  • V7200

    VS-5584

    PI3K inhibitor.

    ≥98%
  • D0025

    DAMGO

    Synthetic peptice; μOR agonist.

    ≥95%
  • G5752

    Gonadorelin Acetate

    Synthetic peptide, GnRH derivative; GnRH agonist.
    ≥95%
  • C3477

    Citalopram Hydrobromide

    SERT inhibitor.

    ≥98%
  • C2956

    Cholecalciferol

    Endogenous vitamin D prodrug.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only